Scientists have uncovered antibodies that target the "dark side" of the flu virus.
Influenza viruses have a mushroom-shaped protein known as neuraminidase (NA) that is said to have a "dark side" because the structure beneath its mushroom cap has been largely unexplored by science. Antibodies that latch onto this dark side could help form the basis for antiviral drugs and vaccines that work against many flu viruses, researchers wrote in a paper published Friday (March 1) in the journal Immunity.
